Correlation Between Lyra Therapeutics and Harrow Health

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Harrow Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Harrow Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and Harrow Health 8625, you can compare the effects of market volatilities on Lyra Therapeutics and Harrow Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Harrow Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Harrow Health.

Diversification Opportunities for Lyra Therapeutics and Harrow Health

-0.34

Correlation Coefficient

Lyra Therapeutics  Harrow Health

Very good diversification

The 3 months correlation between Lyra and Harrow is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Harrow Health 8625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harrow Health 8625 and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Harrow Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harrow Health 8625 has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Harrow Health go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and Harrow Health

Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Harrow Health. In addition to that, Lyra Therapeutics is 11.84 times more volatile than Harrow Health 8625. It trades about -0.12 of its total potential returns per unit of risk. Harrow Health 8625 is currently generating about 0.0 per unit of volatility. If you would invest  2,540  in Harrow Health 8625 on September 27, 2024 and sell it today you would lose (1.40) from holding Harrow Health 8625 or give up 0.06% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lyra Therapeutics  vs.  Harrow Health 8625

Lyra Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Harrow Health 8625

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health 8625 are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Harrow Health is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Lyra Therapeutics and Harrow Health

The main advantage of trading using opposite Lyra Therapeutics and Harrow Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Harrow Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harrow Health will offset losses from the drop in Harrow Health's long position.

The idea behind Lyra Therapeutics and Harrow Health 8625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.